• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 174-188 of 260 results

1033 Exhibit: Ex 1033 Shargel Wal Mart Receipts

Document IPR2015-01344, No. 1033 Exhibit - Ex 1033 Shargel Wal Mart Receipts (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1007 Exhibit: Ex 1007 US5714504 Lindberg

Document IPR2015-01344, No. 1007 Exhibit - Ex 1007 US5714504 Lindberg (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1049 Exhibit: Ex 1049 Effects of Single and Repeated Doses Howden

Document IPR2015-01344, No. 1049 Exhibit - Ex 1049 Effects of Single and Repeated Doses Howden (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1012 Exhibit: Ex 1012 US4757060 Lukacsko

Document IPR2015-01344, No. 1012 Exhibit - Ex 1012 US4757060 Lukacsko (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1029 Exhibit: Ex 1029 US6319519 Woolfe

Document IPR2015-01344, No. 1029 Exhibit - Ex 1029 US6319519 Woolfe (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1018 Exhibit: Ex 1018 Effect of Orally Administered Prostaglandin Karim

Document IPR2015-01344, No. 1018 Exhibit - Ex 1018 Effect of Orally Administered Prostaglandin Karim (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1051 Exhibit: Ex 1051The Effects of Oral Doses Tolman

Document IPR2015-01344, No. 1051 Exhibit - Ex 1051The Effects of Oral Doses Tolman (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1040 Exhibit: Ex 1040 US6262085 Whittle

Document IPR2015-01344, No. 1040 Exhibit - Ex 1040 US6262085 Whittle (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1039 Exhibit: Ex 1039 WO9854171 Astra Aktiebolag

Document IPR2015-01344, No. 1039 Exhibit - Ex 1039 WO9854171 Astra Aktiebolag (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1013 Exhibit: Ex 1013 The Mechanism of Action of Aspirin Vane

Document IPR2015-01344, No. 1013 Exhibit - Ex 1013 The Mechanism of Action of Aspirin Vane (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1048 Exhibit: Ex 1048 Development of an Oral Formulation Pilbrant

Document IPR2015-01344, No. 1048 Exhibit - Ex 1048 Development of an Oral Formulation Pilbrant (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1053 Exhibit: Ex 1053 Clinical Trial Evaluation Miner

Document IPR2015-01344, No. 1053 Exhibit - Ex 1053 Clinical Trial Evaluation Miner (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1042 Exhibit: Ex 1042 US5051262 Panoz

Document IPR2015-01344, No. 1042 Exhibit - Ex 1042 US5051262 Panoz (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1041 Exhibit: Ex 1041 US20010000468 Mak

Document IPR2015-01344, No. 1041 Exhibit - Ex 1041 US20010000468 Mak (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze

1037 Exhibit: Ex 1037 The Random House Dictionary

Document IPR2015-01344, No. 1037 Exhibit - Ex 1037 The Random House Dictionary (P.T.A.B. Jun. 5, 2015)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 12 13 14 15 16 17 18 >>